Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study-Reference-Cited by-同舟云学术

Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study

Published:2007-10 Issue:10 Volume:101 Page:2065-2075
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Chuchalin Alexander G.,Tsoi Alla N.,Richter Kai,Krug Norbert,Dahl Ronald,Luursema P.B.,Cameron Ray,Bao Weibin,Higgins Mark,Woessner Ralph,van As Andre

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NIH Publication 02-3659 issued January 1995 (updated 2006; accessed 24 January 2007). Available from: 〈http://www.ginasthma.com〉.

2. Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis;Ram;Thorax,2003

3. Short-acting beta2 agonists for stable chronic obstructive pulmonary disease;Sestini;Cochrane Database Syst Rev,2002

4. Adverse effects of beta-agonists;Sears;J Allergy Clin Immunol,2002

5. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action;Battram;J Pharmacol Exp Ther,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly sensitive liquid chromatography–mass spectrometry method for the quantitative analysis of mometasone furoate in human plasma: Method validation and application to clinical pharmacokinetic studies;Biomedical Chromatography;2024-04-10

2. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023

3. Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma;Biomedicines;2022-09-19

4. Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma;Expert Review of Respiratory Medicine;2021-12-23

5. Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma;Expert Review of Respiratory Medicine;2021-12-22